{"id":"https://openalex.org/W4409628811","doi":"https://doi.org/10.1158/1538-7445.am2025-4225","title":"Abstract 4225: Targeting RNA splicing sensitizes MTAP-deleted cancers to MTA-cooperative PRMT5 inhibitors","display_name":"Abstract 4225: Targeting RNA splicing sensitizes MTAP-deleted cancers to MTA-cooperative PRMT5 inhibitors","publication_year":2025,"publication_date":"2025-04-21","ids":{"openalex":"https://openalex.org/W4409628811","doi":"https://doi.org/10.1158/1538-7445.am2025-4225"},"language":"en","primary_location":{"id":"doi:10.1158/1538-7445.am2025-4225","doi":"https://doi.org/10.1158/1538-7445.am2025-4225","is_oa":false,"landing_page_url":"https://doi.org/10.1158/1538-7445.am2025-4225","pdf_url":null,"source":{"id":"https://openalex.org/S168522863","display_name":"Cancer Research","issn_l":"0008-5472","issn":["0008-5472","1538-7445"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer Research","raw_type":"journal-article"},"volume":null,"type":"conference-abstract","indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5041299254","display_name":"Katherine K. Slemmons","orcid":"https://orcid.org/0000-0003-3700-5633","observed_orcids":["https://orcid.org/0000-0003-3700-5633"]},"institutions":[{"id":"https://openalex.org/I1320553840","display_name":"Amgen (United States)","ror":"https://ror.org/03g03ge92","country_code":"US","type":"company","lineage":["https://openalex.org/I1320553840"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Katherine K. Slemmons","raw_affiliation_strings":["1Amgen, Thousand Oaks, CA;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Amgen, Thousand Oaks, CA;","institution_ids":["https://openalex.org/I1320553840"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5057792439","display_name":"Chun Su","orcid":"https://orcid.org/0000-0001-6388-8666","observed_orcids":["https://orcid.org/0000-0001-6388-8666"]},"institutions":[{"id":"https://openalex.org/I1320553840","display_name":"Amgen (United States)","ror":"https://ror.org/03g03ge92","country_code":"US","type":"company","lineage":["https://openalex.org/I1320553840"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Chun Su","raw_affiliation_strings":["2Amgen, South San Francisco, CA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"2Amgen, South San Francisco, CA","institution_ids":["https://openalex.org/I1320553840"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5045902124","display_name":"Siyuan Liu","orcid":"https://orcid.org/0009-0003-3145-9252","observed_orcids":["https://orcid.org/0009-0003-3145-9252"]},"institutions":[{"id":"https://openalex.org/I1320553840","display_name":"Amgen (United States)","ror":"https://ror.org/03g03ge92","country_code":"US","type":"company","lineage":["https://openalex.org/I1320553840"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Siyuan Liu","raw_affiliation_strings":["1Amgen, Thousand Oaks, CA;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Amgen, Thousand Oaks, CA;","institution_ids":["https://openalex.org/I1320553840"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5113344576","display_name":"Po-Wen Yu","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1320553840","display_name":"Amgen (United States)","ror":"https://ror.org/03g03ge92","country_code":"US","type":"company","lineage":["https://openalex.org/I1320553840"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Po-Wen Yu","raw_affiliation_strings":["1Amgen, Thousand Oaks, CA;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Amgen, Thousand Oaks, CA;","institution_ids":["https://openalex.org/I1320553840"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5071012597","display_name":"Michele McEntee","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1320553840","display_name":"Amgen (United States)","ror":"https://ror.org/03g03ge92","country_code":"US","type":"company","lineage":["https://openalex.org/I1320553840"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Michele McEntee","raw_affiliation_strings":["2Amgen, South San Francisco, CA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"2Amgen, South San Francisco, CA","institution_ids":["https://openalex.org/I1320553840"]}]},{"author_position":"middle","author":{"id":null,"display_name":"Eric Yuan","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1320553840","display_name":"Amgen (United States)","ror":"https://ror.org/03g03ge92","country_code":"US","type":"company","lineage":["https://openalex.org/I1320553840"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Eric Yuan","raw_affiliation_strings":["2Amgen, South San Francisco, CA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"2Amgen, South San Francisco, CA","institution_ids":["https://openalex.org/I1320553840"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5001400694","display_name":"Jasper Lee","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1320553840","display_name":"Amgen (United States)","ror":"https://ror.org/03g03ge92","country_code":"US","type":"company","lineage":["https://openalex.org/I1320553840"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Jasper Lee","raw_affiliation_strings":["2Amgen, South San Francisco, CA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"2Amgen, South San Francisco, CA","institution_ids":["https://openalex.org/I1320553840"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5073479947","display_name":"Jiamiao Lu","orcid":"https://orcid.org/0000-0002-5125-6511","observed_orcids":["https://orcid.org/0000-0002-5125-6511"]},"institutions":[{"id":"https://openalex.org/I1320553840","display_name":"Amgen (United States)","ror":"https://ror.org/03g03ge92","country_code":"US","type":"company","lineage":["https://openalex.org/I1320553840"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Jiamiao Lu","raw_affiliation_strings":["2Amgen, South San Francisco, CA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"2Amgen, South San Francisco, CA","institution_ids":["https://openalex.org/I1320553840"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5061902626","display_name":"Aaron M. Horning","orcid":"https://orcid.org/0000-0003-3247-0798","observed_orcids":["https://orcid.org/0000-0003-3247-0798"]},"institutions":[{"id":"https://openalex.org/I1320553840","display_name":"Amgen (United States)","ror":"https://ror.org/03g03ge92","country_code":"US","type":"company","lineage":["https://openalex.org/I1320553840"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Aaron Horning","raw_affiliation_strings":["2Amgen, South San Francisco, CA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"2Amgen, South San Francisco, CA","institution_ids":["https://openalex.org/I1320553840"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5091742726","display_name":"Antreas A. Hindoyan","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1320553840","display_name":"Amgen (United States)","ror":"https://ror.org/03g03ge92","country_code":"US","type":"company","lineage":["https://openalex.org/I1320553840"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Antreas Hindoyan","raw_affiliation_strings":["1Amgen, Thousand Oaks, CA;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Amgen, Thousand Oaks, CA;","institution_ids":["https://openalex.org/I1320553840"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5021750238","display_name":"Brian Belmontes","orcid":"https://orcid.org/0000-0003-0141-1007","observed_orcids":["https://orcid.org/0000-0003-0141-1007"]},"institutions":[{"id":"https://openalex.org/I1320553840","display_name":"Amgen (United States)","ror":"https://ror.org/03g03ge92","country_code":"US","type":"company","lineage":["https://openalex.org/I1320553840"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Brian Belmontes","raw_affiliation_strings":["1Amgen, Thousand Oaks, CA;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Amgen, Thousand Oaks, CA;","institution_ids":["https://openalex.org/I1320553840"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5102816712","display_name":"Paul E. Hughes","orcid":"https://orcid.org/0000-0003-1095-9883","observed_orcids":["https://orcid.org/0000-0003-1095-9883"]},"institutions":[{"id":"https://openalex.org/I1320553840","display_name":"Amgen (United States)","ror":"https://ror.org/03g03ge92","country_code":"US","type":"company","lineage":["https://openalex.org/I1320553840"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Paul E. Hughes","raw_affiliation_strings":["1Amgen, Thousand Oaks, CA;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Amgen, Thousand Oaks, CA;","institution_ids":["https://openalex.org/I1320553840"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":["https://openalex.org/I1320553840"],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":3,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":"85","issue":"8_Supplement_1","first_page":"4225","last_page":"4225"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T13157","display_name":"Cancer-related gene regulation","score":0.9883000254631042,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T13157","display_name":"Cancer-related gene regulation","score":0.9883000254631042,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10604","display_name":"RNA Research and Splicing","score":0.005799999926239252,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T12534","display_name":"Protein Degradation and Inhibitors","score":0.0006000000284984708,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/mtap-deletion","display_name":"MTAP deletion","score":0.9210000038146973},{"id":"https://openalex.org/keywords/prmt5-inhibitors","display_name":"PRMT5 inhibitors","score":0.8529999852180481},{"id":"https://openalex.org/keywords/alternative-splicing","display_name":"alternative splicing","score":0.7900000214576721},{"id":"https://openalex.org/keywords/intron-retention","display_name":"intron retention","score":0.9319999814033508},{"id":"https://openalex.org/keywords/pre-mrna-splicing","display_name":"pre-mRNA splicing","score":0.8389999866485596},{"id":"https://openalex.org/keywords/rna-processing","display_name":"RNA processing","score":0.5709999799728394},{"id":"https://openalex.org/keywords/drug-sensitivity","display_name":"drug sensitivity","score":0.3970000147819519},{"id":"https://openalex.org/keywords/crispr-knockout-screen","display_name":"CRISPR knockout screen","score":0.6880000233650208},{"id":"https://openalex.org/keywords/spliceosome","display_name":"spliceosome","score":0.7960000038146973},{"id":"https://openalex.org/keywords/tumor-regression","display_name":"tumor regression","score":0.4090000092983246},{"id":"https://openalex.org/keywords/biomarkers","display_name":"biomarkers","score":0.4180000126361847},{"id":"https://openalex.org/keywords/combination-cancer-therapy","display_name":"combination cancer therapy","score":0.5},{"id":"https://openalex.org/keywords/hap1","display_name":"HAP1","score":0.4620000123977661},{"id":"https://openalex.org/keywords/a549-cells","display_name":"A549 cells","score":0.9139999747276306}],"concepts":[{"id":"https://openalex.org/C54458228","wikidata":"https://www.wikidata.org/wiki/Q237218","display_name":"RNA splicing","level":4,"score":0.6740636825561523},{"id":"https://openalex.org/C67705224","wikidata":"https://www.wikidata.org/wiki/Q11053","display_name":"RNA","level":3,"score":0.5678846836090088},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.4867439270019531},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.46765822172164917},{"id":"https://openalex.org/C70721500","wikidata":"https://www.wikidata.org/wiki/Q177005","display_name":"Computational biology","level":1,"score":0.4310725927352905},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.37040483951568604},{"id":"https://openalex.org/C60644358","wikidata":"https://www.wikidata.org/wiki/Q128570","display_name":"Bioinformatics","level":1,"score":0.3412591218948364},{"id":"https://openalex.org/C54355233","wikidata":"https://www.wikidata.org/wiki/Q7162","display_name":"Genetics","level":1,"score":0.23982366919517517},{"id":"https://openalex.org/C104317684","wikidata":"https://www.wikidata.org/wiki/Q7187","display_name":"Gene","level":2,"score":0.16377288103103638}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1158/1538-7445.am2025-4225","doi":"https://doi.org/10.1158/1538-7445.am2025-4225","is_oa":false,"landing_page_url":"https://doi.org/10.1158/1538-7445.am2025-4225","pdf_url":null,"source":{"id":"https://openalex.org/S168522863","display_name":"Cancer Research","issn_l":"0008-5472","issn":["0008-5472","1538-7445"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer Research","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"score":0.8371999859809875,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"sustainable_development_goals_aurora":[],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W4224241862","https://openalex.org/W2889547007","https://openalex.org/W1510729279","https://openalex.org/W2587969176","https://openalex.org/W2971615643","https://openalex.org/W2076384244","https://openalex.org/W2106965934","https://openalex.org/W2740646169","https://openalex.org/W2182232875","https://openalex.org/W2147993839"],"abstract_inverted_index":{"Abstract":[0],"AMG":[1,50,80,117,205,221],"193,":[2,51],"currently":[3,376],"in":[4,21,28,33,60,66,92,99,173,230,249,254,262,265,313,328,334,349,380,383],"Phase":[5],"1/2":[6],"trials,":[7],"is":[8,14,202,228,346],"an":[9],"MTA-cooperative":[10,159,245,362,439],"PRMT5":[11,59,149,160,194,246,280,326,363,440],"inhibitor":[12],"that":[13,98,140,193,239,343,353],"showing":[15],"promise":[16],"as":[17,126,218],"a":[18,90,100,127,136,164,250,259,316,347],"targeted":[19],"therapy":[20],"MTAP-deleted":[22,71,146,175,182,256,308,329,350,436],"tumors.":[23],"MTAP":[24,335],"deletion,":[25],"which":[26,275],"occurs":[27],"\u223c10-15%":[29],"of":[30,36,45,63,70,109,154,166,212,220,233,286,290,297,300,361,445],"cancers,":[31],"results":[32],"the":[34,42,46,61,231,271,288,301,359,372,391,446],"accumulation":[35],"its":[37,53],"substrate":[38],"MTA":[39,64],"leading":[40],"to":[41,116,148,158,244,279,310,357,399,438],"partial":[43],"inhibition":[44,69,195,247,281,285,327],"arginine":[47],"methyltransferase":[48],"PRMT5.":[49],"and":[52,89,180,199,215,258,267,367,382],"representative":[54],"analog":[55],"AM-9747,":[56],"selectively":[57],"bind":[58],"presence":[62],"resulting":[65,248],"preferential":[67],"growth":[68,284],"tumor":[72,102,283,294],"cells":[73,147,257,309],"while":[74],"sparing":[75],"normal":[76],"WT":[77,336],"cells.":[78,269,337],"Mechanistically,":[79],"193":[81,118,206,222],"treatment":[82,312,320],"induces":[83,196],"DNA":[84],"damage,":[85],"cell":[86,103,176,183,330,351],"cycle":[87],"arrest,":[88],"change":[91],"alternative":[93,120,197,234,344],"splicing.":[94,235],"We":[95],"previously":[96],"showed":[97],"large":[101],"line":[104,188],"panel,":[105],"elevated":[106],"baseline":[107],"levels":[108],"intron":[110,200],"retention":[111,201],"positively":[112],"correlated":[113],"with":[114,189,204,321,325],"sensitivity":[115,243,278],"suggesting":[119],"splicing":[121,143,198,214,304,345,434],"could":[122,144],"potentially":[123],"be":[124,355,397],"utilized":[125,398],"biomarker":[128,388],"(Belmontes":[129],"&":[130],"Slemmons":[131],"et":[132],"al,":[133],"2024).":[134],"As":[135],"result,":[137],"we":[138,162,237],"hypothesized":[139],"co-targeting":[141],"pre-mRNA":[142,213],"sensitize":[145],"inhibition.":[150],"To":[151],"identify":[152],"modulators":[153,219],"response":[155],"or":[156,303],"resistance":[157,366],"inhibitors,":[161],"performed":[163],"series":[165],"drug":[167],"anchored":[168],"genome-wide":[169],"CRISPR":[170,373],"knockout":[171,241,292],"screens":[172,209,374],"engineered":[174],"lines":[177,184,331,352],"(HAP1,":[178],"HCT116)":[179],"endogenous":[181],"(A549,":[185],"MIAPACA2).":[186],"In":[187,270,315,338],"our":[190,340],"previous":[191],"data":[192,341],"associated":[203],"sensitivity,":[207],"these":[208,401],"identified":[210,370],"components":[211,299],"RNA":[216,433],"processing":[217],"response.":[223],"One":[224],"exemplary":[225],"hit,":[226],"AKAP17A,":[227],"involved":[229],"regulation":[232],"Here":[236],"demonstrate":[238],"AKAP17A":[240,291],"drives":[242,293],"3-4X":[251],"IC50":[252],"decrease":[253],"HAP1":[255],"30%":[260],"increase":[261],"max":[263],"effect":[264],"A549":[266],"MIAPACA2":[268,272],"xenograft":[273],"model,":[274],"has":[276],"moderate":[277],"(average":[282],"\u223c50%),":[287],"addition":[289],"regressions.":[295],"Knockout":[296],"other":[298],"spliceosome":[302,322],"regulators":[305],"similarly":[306],"sensitizes":[307,435],"AM-9747":[311],"vitro.":[314],"complementary":[317],"pharmacologic":[318],"approach,":[319],"inhibitors":[323,441],"synergizes":[324],"but":[332],"not":[333],"summary,":[339],"suggests":[342],"vulnerability":[348],"can":[354],"perturbed":[356],"augment":[358],"activity":[360],"inhibitors.":[364],"Additional":[365],"sensitization":[368],"pathways":[369],"from":[371,390],"are":[375],"being":[377],"evaluated":[378],"using":[379],"vitro":[381],"vivo":[384],"assays.":[385],"Furthermore,":[386],"clinical":[387],"datasets":[389],"ongoing":[392],"early":[393],"phase":[394],"trials":[395],"will":[396],"validate":[400],"preclinical":[402],"findings.":[403],"Citation":[404],"Format:":[405],"Katherine":[406],"K.":[407],"Slemmons,":[408],"Chun":[409],"Su,":[410],"Siyuan":[411],"Liu,":[412],"Po-Wen":[413],"Yu,":[414],"Michele":[415],"McEntee,":[416],"Eric":[417],"Yuan,":[418],"Jasper":[419],"Lee,":[420],"Jiamiao":[421],"Lu,":[422],"Aaron":[423],"Horning,":[424],"Antreas":[425],"Hindoyan,":[426],"Brian":[427],"Belmontes,":[428],"Paul":[429],"E.":[430],"Hughes.":[431],"Targeting":[432],"cancers":[437],"[abstract].":[442],"In:":[443],"Proceedings":[444],"American":[447],"Association":[448],"for":[449],"Cancer":[450,467],"Research":[451],"Annual":[452],"Meeting":[453],"2025;":[454],"Part":[455],"1":[456],"(Regular":[457],"Abstracts);":[458],"2025":[459],"Apr":[460],"25-30;":[461],"Chicago,":[462],"IL.":[463],"Philadelphia":[464],"(PA):":[465],"AACR;":[466],"Res":[468],"2025;85(8_Suppl_1):Abstract":[469],"nr":[470],"4225.":[471]},"counts_by_year":[{"year":2025,"cited_by_count":3}],"updated_date":"2026-10-09T09:14:12.587421","created_date":"2025-10-10T00:00:00"}